Crossmark

Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease

Crossref DOI link: https://doi.org/10.1186/s13058-014-0418-6

Published Online: 2014-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Knox, Aaron J

Scaling, Allison L

Pinto, Mauricio P

Bliesner, Brian S

Haughian, James M

Abdel-Hafiz, Hany A

Horwitz, Kathryn B
License Information

Text and Data Mining valid from 2014-08-13

Version of Record valid from 2014-08-13
More Information

Article History

Received: 11 February 2014

Accepted: 22 July 2014

First Online: 13 August 2014

Document is current

Any future updates will be listed below